Breaking News

ANNUAL REPORT 2023 | Unveiling TIF’s Impactful Achievements
REGULATORY APPROVAL | PiaSky Becomes the First Monthly Treatment for PNH in the EU
ACCESS TO INNOVATION | UK Greenlights Gene-Editing Therapy Casgevy for β-Thalassaemia Treatment
GLOBAL SURVEY | Understanding the Thalassaemia Community Health Literacy & Its Impact on Care
Understanding the Thalassaemia Community Health Literacy and Its Impact on Care
JUST LISTEN | Voices of PK Deficiency Episode on the Impact of New International Standards
NEW APPROVAL | FDA Endorses Piasky for Paroxysmal Nocturnal Hemoglobinuria
CAD | Enjaymo Not Cost-Effective at Current Price, According to US Study
SPOTLIGHT | TIF Wins Prestigious HemaSphere Award at EHA2024
NEW PUBLICATION | Nutrition in Thalassaemia: A Guide for Patients, Families, and Caregivers

English

Menu

Home
Who we are
What we do
Haemoglobin Disorders
Positions & Policies
Publications
Media Centre
- News
- Newsletters
- Events
- Videos
Contact us

Search for

Home/Newsletter/TIF Newsletter – May 2020

TIF Newsletter – May 2020

An Edition Focusing on COVID-19

Less than a minute

Tags

TIF News COVID-19 Pandemic COVID-19 Haemoglobin Disorders Newslettters Patients Healthcare Professionals

Less than a minute

Facebook X LinkedIn Share via Email Print

Related Articles

TIF Newsletter – August 2023

September 4, 2023

TIF Newsletter – December 2022

December 30, 2022

TIF Newsletter – June 2023

July 6, 2023

TIF Newsletter – October 2023

November 9, 2023

Check Also

News

TOP STORY | EMA Validates Vertex’s/CRISPR Submission Of Exa-Cel For β-Τhal And SCD
January 26, 2023

Quick links

For Patients
For Healthcare Professionals
For Associations
For Supporters
TIF Members
Useful Links
Sitemap

Follow us

Facebook
X
LinkedIn
YouTube
Instagram
RSS

© Copyright 2024, All Rights Reserved |

Powered by Genestial

Transparency Statement | Privacy Policy

Facebook X WhatsApp

Back to top button

Close

Facebook
X
LinkedIn
YouTube
Instagram
RSS

Search for: